Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
TMS, H coil · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| TMS, High Frequency | ACTIVE_COMPARATOR | High Frequency TMS with H coil to prefrontal cortex |
| TMS, Low Frequency | ACTIVE_COMPARATOR | Low Frequency TMS to Prefrontal cortex |
| Sham Stimulation | PLACEBO_COMPARATOR | Sham TMS with H Coil on Prefrontal Cortex |
| Name | Type | Description |
|---|---|---|
| TMS, H coil | DEVICE | TMS, H Coil, High/ Low Frequency |
Inclusion Criteria: 1. Men and women aged 50-85. 2. Diagnosed with Alzheimer's disease for at least one year (by the DSM-IV criteria). 3. Scored below 24 on the MMSE. 4. Received drug therapy for their disease, with each treatment having been administered at an acceptable dosage for at least 5 week...
Top 20 of 24 competitors
TMS, H coil is an investigational deep transcranial magnetic stimulation device being studied for the treatment of Alzheimer's Disease. It is currently in Phase 2 clinical development and has not been approved by regulatory authorities. The device is being evaluated for its potential to address symptoms of this neurological condition.
TMS, H coil is being developed by BrainsWay Ltd., a company publicly traded under the ticker symbol BWAY. The company is conducting clinical research to evaluate this deep transcranial magnetic stimulation device for Alzheimer's Disease. BrainsWay is responsible for the ongoing development and potential commercialization of this investigational therapy.
TMS, H coil is currently in Phase 2 clinical development for Alzheimer's Disease. It is an investigational device that has not yet received regulatory approval. The Phase 2 trial has been completed, and the device remains under evaluation for safety and efficacy in this patient population.
TMS, H coil has one completed Phase 2 clinical trial registered under NCT01179373, titled "Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease." This randomized, double-blind, placebo-controlled study enrolled 45 participants in Israel, with a minimum age of 50 years, and included both sexes.
TMS, H coil is a specific type of deep transcranial magnetic stimulation device. The clinical trial NCT01179373 evaluates this device for Alzheimer's Disease treatment. While TMS, H coil refers to the specific coil configuration used, deep transcranial magnetic stimulation is the broader technology category to which this device belongs.